
Number of publications published per year by Hashimoto, Yoshimasa. (Source : PubMed)

Distribution of publications types for Hashimoto, Yoshimasa. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Clinical and virological effects of long-term (over 5 years) lamivudine therapy.
J. Med. Virol.
2010;82;4
Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer.
Annals of surgical oncology
2010
Local overexpression of interleukin-1 family, member 6 relates to the development of tubulointerstitial lesions.
Lab. Invest.
2010;90;3
A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy.
Oncogene
2010;29;8
Overexpression of interferon-activated gene 202 (Ifi202) correlates with the progression of autoimmune glomerulonephritis associated with the MRL chromosome 1.
Lupus
2010
Embryonal rhabdomyosarcoma of the prostate.
Int. J. Clin. Oncol.
2010;15;1
Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.
Carcinogenesis
2010
Endoscopic biliary stenting successfully managed mucus obstructive jaundice in intraductal papillary mucinous carcinoma.
Endoscopy
2010;42 Suppl 2
Middle pancreatectomy with pancreaticogastrostomy: a technique, operative outcomes, and long-term pancreatic function.
J Surg Oncol
2010;101;1
miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer.
Int. J. Cancer
2009
[ See timeline ] [ See all publications ]
means that Hashimoto, Yoshimasa has 30 papers cited a least 30 times - methodology
Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan, .
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.